BRIEF REPORT: Compound EGFR mutations and response to EGFR tyrosine kinase inhibitors

INTRODUCTION: Non-small-cell lung cancers (NSCLCs) containing epidermal growth factor receptor (EGFR) mutations are exquisitely sensitive to EGFR tyrosine kinase inhibitors (TKIs). This is the case of the most common EGFR mutations affecting exon 18 (G719X), 19 (inframe deletions) and 21 (L858R and...

Full description

Saved in:
Bibliographic Details
Main Authors: Kobayashi, Susumu, Canepa, Hannah M., Bailey, Alexandra S., Nakayama, Sohei, Yamaguchi, Norihiro, Goldstein, Michael A., Huberman, Mark S., Costa, Daniel B.
Format: Artigo
Language:Inglês
Published: 2013
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3531043/
https://ncbi.nlm.nih.gov/pubmed/23242437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e3182781e35
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items